460 related articles for article (PubMed ID: 27350898)
1. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
PeerJ; 2016; 4():e2119. PubMed ID: 27350898
[TBL] [Abstract][Full Text] [Related]
2. Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.
Mohamad Yusof A; Jamal R; Muhammad R; Abdullah Suhaimi SN; Mohamed Rose I; Saidin S; Ab Mutalib NS
Front Endocrinol (Lausanne); 2018; 9():158. PubMed ID: 29713312
[TBL] [Abstract][Full Text] [Related]
3. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
4. hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B.
Lu H; Zhu C; Ruan Y; Fan L; Ruan Z; Chen Q; Yuan J; Xu Y; Wang H; Wei Q
Biomed Res Int; 2022; 2022():7488708. PubMed ID: 35342753
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
6. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
Front Oncol; 2020; 10():756. PubMed ID: 32509578
[TBL] [Abstract][Full Text] [Related]
8. Identification of key miRNAs in papillary thyroid carcinoma based on data mining and bioinformatics methods.
Wang J; Wu L; Jin Y; Li S; Liu X
Biomed Rep; 2020 Jan; 12(1):11-16. PubMed ID: 31839944
[TBL] [Abstract][Full Text] [Related]
9. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling and bioinformatics analysis of serum exosomal circular RNAs in lymph node metastasis of papillary thyroid carcinoma.
Peng H; Zhu Z; Xing J; Xu Q; Man C; Wang S; Liu Y; Zhang Z
J Biomed Res; 2024 May; ():1-15. PubMed ID: 38812291
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning.
Yang F; Zhang J; Li B; Zhao Z; Liu Y; Zhao Z; Jing S; Wang G
Int J Endocrinol; 2021; 2021():3984463. PubMed ID: 34335744
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis.
Wang Z; Zhang H; Zhang P; Li J; Shan Z; Teng W
Med Oncol; 2013; 30(2):577. PubMed ID: 23609190
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
[TBL] [Abstract][Full Text] [Related]
14. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.
Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K
Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Chen Q; Zeng X; Huang D; Qiu X
Cancer Manag Res; 2018; 10():6489-6504. PubMed ID: 30568508
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of microRNAs as the risk factor of lymph node metastasis in papillary thyroid carcinoma: systematic review.
Laukiene R; Jakubkevicius V; Ambrozaityte L; Cimbalistiene L; Utkus A
Endokrynol Pol; 2021; 72(2):145-152. PubMed ID: 33970479
[TBL] [Abstract][Full Text] [Related]
17. MiR-324-5p assists ultrasonography in predicting lymph node metastasis of unifocal papillary thyroid microcarcinoma without extracapsular spread.
Yang Y; Xia S; Ni X; Ni Z; Zhang L; Wang W; Kong Y; Wang Y; Ye L; Zhan W
Oncotarget; 2017 Oct; 8(48):83802-83816. PubMed ID: 29137384
[TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients.
Wang K; Li H; Zhao J; Yao J; Lu Y; Dong J; Bai J; Liao L
Front Cell Dev Biol; 2022; 10():1001954. PubMed ID: 36568979
[No Abstract] [Full Text] [Related]
19. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
[TBL] [Abstract][Full Text] [Related]
20. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]